Evidence map›Paper›PMID 33994556›Full record

ArticleChemistry of heterocyclic compounds2021

Recent advances on heterocyclic compounds with antiviral properties.

Aramita De, Subhankar Sarkar, Adinath Majee

Open access · bronzeAbstract read
In one paragraph

Article in Chemistry of heterocyclic compounds, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Recent Advances in Nitrogen-Containing Heterocyclic Scaffolds as Antiviral Agents.Medicinal chemistry (Shariqah (United Arab Emirates)) · 2024
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Novel 1,2,4-Triazole- and Tetrazole-Containing 4Molecules (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Novel [1,2,4]triazolo[3,4-Molecules (Basel, Switzerland) · 2022
    Article
  12. Seeking heterocyclic scaffolds as antivirals against dengue virus.European journal of medicinal chemistry · 2022
    Review
  13. RSC advances · 2022
    Article
  14. Pyridine Compounds with Antimicrobial and Antiviral Activities.International journal of molecular sciences · 2022
    Review
  15. Synthesis of isomeric 4-(Chemistry of heterocyclic compounds · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Aramita DeDepartment of Chemistry, Visva-Bharati, Santiniketan, West Bengal 731235 India.
Subhankar SarkarDepartment of Chemistry, Visva-Bharati, Santiniketan, West Bengal 731235 India.
Adinath MajeeDepartment of Chemistry, Visva-Bharati, Santiniketan, West Bengal 731235 India.
Visva-Bharati University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years several important viral infections have emerged and antiviral chemotherapeutic agents are not sufficiently effective in clinic, leading to serious human diseases and mortality. Therefore, novel antiviral candidates are urgently desirable, which undoubtedly is essential for the therapy of various fatal and debilitating viral infections. Heterocyclic compounds are obtaining importance in the field of medicinal chemistry because of the broad spectrum of their physiological activities. Among N- and S-containing heterocycles, indole, imidazole, thiazole, pyridine, and quinaxoline derivatives are especially attractive. The present review highlights antiviral behavior of these heterocyclic compounds.

Indexed as

antiviral activitybiological activitycytotoxicityvirus

Identifiers

PMID33994556
PMCPMC8113790
OpenAlexW3158188948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.